Cell Biosciences

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Paired Ends

Premium

Sam Mohan

The protein analysis firm also said that it raised $13 million in connection with the deal.

New Products

Premium

Cell Biosciences

Paired Ends

Premium

Mark Dronsfield, Bernd Brust, Jeremy Berg, Mark Poznansky

A number of prominent proteomics-based diagnostics developers were recipients of the grant and tax credit awards, which are being provided by the IRS through the Patient Protection and Affordable Care Act's Qualifying Therapeutic Discovery Project Program.

Paired Ends

Premium

Lloyd Kunimoto, Martin Burow, Richard Lussier, Ingrid Choupin

With the assay, the Stanford researchers have begun examining protein phosphorylation levels in a variety of cancer types. The team has also entered into collaborations with several pharmaceutical firms to investigate the effects of therapeutic agents on protein phosphorylation levels in tumor cells.

The deal is expected to expand Cell Biosciences' protein analysis product portfolio "and transform Cell Biosciences into the premier provider of capillary-based protein analysis technology," the company said.

New Products

Premium

Cell Biosciences, Proteome Software, TTP LabTech

Pages

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.